Tirzepatide Doesn't Seem to Be Working — Here's What That Usually Means

The biggest misconception: the early weeks should show dramatic results

Most people who feel tirzepatide isn't working reach that conclusion within the first month, often at the 2.5mg starting dose. That conclusion is understandable but almost always premature. The 2.5mg pen exists to let your body adjust to the medicine, its job is to reduce the chance of nausea and other gastrointestinal effects, not to drive significant weight loss. Expecting the scales to shift substantially at that stage is a bit like judging a long journey by the first junction.

The SURMOUNT-1 trial published in the New England Journal of Medicine tracked thousands of adults over 72 weeks. Weight reduction accumulated steadily across that period, with the largest average losses (around 20–21% of body weight) seen at the highest dose. The trajectory was gradual. If you're curious about how long it takes for tirzepatide to start working, the evidence points clearly to a longer process where a few weeks of slow progress at a low dose is not treatment failure but almost universally the expected beginning.

If you're wondering more broadly about timelines, our page on how long before tirzepatide starts working covers what the evidence says week by week.

What can genuinely slow or block tirzepatide's effect

There are real reasons (beyond impatience) why tirzepatide may underperform for some people, and they're worth understanding clearly.

Dose level. Appetite suppression and weight loss are strongly dose-dependent with tirzepatide. If you're still on 2.5mg or 5mg because of tolerability concerns, the medicine may not yet be working at its therapeutic best. Titration to the highest well-tolerated dose is central to how the treatment is designed to be used, and that process takes months.

Diet composition. Tirzepatide reduces appetite, but it doesn't override caloric intake entirely. People who find the medicine effective often describe eating noticeably less without trying, but if portion sizes have crept back up, or highly palatable foods are bypassing the fullness signal, weight loss can stall. Protein adequacy matters too; preserving muscle while losing fat requires enough protein in the diet, and low protein intake can distort what the scale shows.

Individual biological variation. Metabolic rate, gut hormone response, genetics, and existing conditions all influence how strongly any GLP-1 or dual-agonist medicine works for a given person. Some people respond robustly at 5mg; others need the full 15mg dose. Neither pattern says anything about willpower or effort.

Medication timing and storage. Tirzepatide must be refrigerated between 2–8°C; a pen that's been stored incorrectly (for instance, left in a hot car or a freezer) may lose potency. Always check the Patient Information Leaflet for the permitted room-temperature window, and contact your prescriber if you're unsure whether a pen has been compromised.

When a plateau is worth raising with your prescriber

A short plateau of two to three weeks is common during titration and usually resolves as the body adjusts. A plateau lasting more than four weeks at a stable dose (especially at a mid-range or lower dose) is worth discussing. It may prompt a review of dose timing, diet, activity level, or whether a dose increase is clinically appropriate.

The NHS medicines page for tirzepatide notes that if you're not losing at least 5% of your body weight after six months at the highest tolerated dose, continuing treatment should be reviewed with your prescriber. That's the clinical benchmark, not a reason to panic mid-titration.

If you've transferred to a new provider or are reviewing whether your current treatment plan makes sense, our page on why tirzepatide may not be working for you specifically goes into more individualised factors. For a broader look at the Mounjaro treatment journey, including what to do if Mounjaro doesn't seem to be working, the Mounjaro overview sets out what the medicine is, how it's prescribed, and what to expect across a full course. And if cost is part of the picture (wondering whether switching provider might help) our Mounjaro price guide explains what legitimate pricing typically includes.

What to do if you believe treatment has genuinely stopped working

Stopping tirzepatide without clinical guidance isn't advisable. Weight can return quickly after discontinuation, and abrupt changes to a titration schedule should always involve a prescriber. The right move is a conversation, not a decision made alone.

At nume, a real prescriber reads every clinical review, not software, not a queue. If your treatment isn't performing as you'd hoped, speaking to our prescribers is the place to start. They can review your current dose, assess whether adjustment is appropriate, and help you understand what realistic progress looks like for your situation. Our clinical team approaches these conversations practically and without judgement, it's a question our prescribers hear regularly, and there's nearly always a useful next step. You can also visit our FAQs for quick answers to common treatment questions, or get in touch with our support team directly.